US Food and Drug Administration is asking de novo and 510(k) sponsors with medical software products to consider being test subjects for the agency's upcoming new precertification (pre-cert) pathway for certain digital health products.
On 22 May, the FDA put out a call to developers of software as a medical device (SaMD) who plan to submit a 510(k) or de novo application this...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?